Insider Transactions in Q1 2022 at Akero Therapeutics, Inc. (AKRO)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2022
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
10,000
-3.13%
|
$170,000
$17.59 P/Share
|
|
Mar 01
2022
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.04%
|
$0
$0.62 P/Share
|
|
Feb 01
2022
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
10,000
-3.13%
|
$170,000
$17.56 P/Share
|
|
Feb 01
2022
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.04%
|
$0
$0.62 P/Share
|
|
Jan 14
2022
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,700
-74.75%
|
$213,400
$22.03 P/Share
|
|
Jan 14
2022
|
William Richard White Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,700
+42.77%
|
$67,900
$7.01 P/Share
|
|
Jan 10
2022
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.13%
|
$0
$0.62 P/Share
|
|
Jan 07
2022
|
Jonathan Young Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
27,744
+14.53%
|
$0
$0.62 P/Share
|
|
Jan 03
2022
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
53,000
+14.64%
|
$0
$0.62 P/Share
|